Lineage Cell Therapeutics (LCTX) EV to FCF (2022)
Lineage Cell Therapeutics' (LCTX) EV to FCF came in at 216.30 for Q4 2022, up 407.4% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) EV to FCF (2022) Analysis & Trends
Since Q1 2022, Lineage Cell Therapeutics has reported EV to FCF for 4 quarters.
- According to Business Quant data, EV to FCF for the three prior quarters was 42.63 (Q3 2022), 51.57 (Q2 2022) and 33.40 (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.67 Bn | 1,100.25 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.68 Bn | 555.54 Bn | 17.30 Bn |
| 3 | AbbVie | 504.96 Bn | 478.07 Bn | 12.70 Bn |
| 4 | Merck | 357.95 Bn | 312.33 Bn | 12.21 Bn |
| 5 | Novartis Ag | 290.91 Bn | 254.90 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.07 Bn | 238.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.58 Bn | 192.98 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.90 Bn | 169.10 Bn | 6.22 Bn |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn |
| 10 | Lineage Cell Therapeutics | 250.75 Mn | 50.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 216.30 |
| Sep 30, 2022 | 42.63 |
| Jun 30, 2022 | 51.57 |
| Mar 31, 2022 | 33.40 |
API Access
Lineage Cell Therapeutics EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();